Cadrenal Therapeutics, Inc. Common Stock
- CVKD
- NASDAQ
- Biotechnology
- Anticoagulant Therapy
- Orphan Drug Development
$1.02
Today −6.42%Quote Oct 19, 2026, 03:49 PM UTC
−2.68%over the last month
Max drawdown −33.9%From 1-month high −17.4%3 months −47.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$3.6M
Quote Oct 19
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$32.00
+3037.3% from here
Floor
$1.00
1.5% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CVKDPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
5